[Conservative treatment of recurrent papillomatosis of the urinary bladder with vitamin A acid. Preliminary report].
D000143:Acids / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000284:Administration, Oral; D002986:Clinical Trials as Topic; D005069:Evaluation Studies as Topic; D005076:Exanthema / Q000139:chemically induced; D005260:Female; D006261:Headache / Q000139:chemically induced; D006801:Humans; D008297:Male; D010212:Papilloma / Q000188:drug therapy*; D012008:Recurrence; D012075:Remission, Spontaneous; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*; D014717:Vertigo / Q000139:chemically induced; D014801:Vitamin A / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D000143:Acids; D014801:Vitamin A
Konservative Behandlung der rezidivierenden Harnblasenpapillomatose mit Vitamin-A-Säure. Vorläufige Mitteilung.